Sustaining long-term follow-up in cell and gene therapies
Diego Correa, VP and global head, CAGT Center of Excellence, IQVIA, and Jip Klerks, product strategy lead, real-world solutions at…
Analysis
ZENBEXUS (iberdomide) for the Treatment of Multiple Myeloma, US
ICH GCP Annex 2 will strengthen sponsor confidence in the use of DCTs and RWD
Podcast: Bringing diversity to Alzheimer’s trials
XOLREMDI (mavorixafor) for the Treatment of WHIM Syndrome, US
How RWD is shaping the next era of healthcare decision-making
ASCO26: AI innovations show promise in reducing the oncology RWD burden
Operation Trialblazer: Expedited IND delivers a strategic edge in dynamic global landscape
